PRISM, a Patient-Reported Outcome Instrument, Accurately Measures Symptom Change in Refractory Gastroesophageal Reflux Disease.
Fuller G, Bolus R, Whitman C, Talley J, Erder MH, Joseph A, Silberg DG, Spiegel B.
Fuller G, et al. Among authors: talley j.
Dig Dis Sci. 2017 Mar;62(3):593-606. doi: 10.1007/s10620-016-4440-7. Epub 2017 Jan 23.
Dig Dis Sci. 2017.
PMID: 28116591
Review.
BACKGROUND: Most patients with gastroesophageal reflux disease (GERD) experience relief following treatment with proton pump inhibitors (PPIs) (Vakil et al. in Am J Gastroenterol 101:1900-1920, 2006; Everhart and Ruhl in Gastroenterology 136:376-386, 2009). ...Most extant …
BACKGROUND: Most patients with gastroesophageal reflux disease (GERD) experience relief following treatment with proton pump inhibitors (PPI …